Supporting people with dementia to navigate hospital admissions
Emma Hughes explains the benefits of her role as a Transitions of Care Admiral Nurse, helping people living with dementia and their families
Related Articles
RCN chief ‘absolutely committed’ to improving pay for all nurses
The RCN chief has renewed her commitment to improving pay for all nursing staff across the UK in a New Year message to the profession.
Survivor’s Guilt: Asking, ‘Why Me?’
Despite being declared cancer-free after initial treatment, I grapple with survivor’s guilt, questioning why my lymphoma responded to therapy while others did not.
FDA Accepts NDA for Avutometinib Plus Defactinib in KRAS+ Low-Grade Serous Ovarian Cancer
An NDA has been accepted by the FDA for the combination of avutometinib and defactinib in KRAS-mutated recurrent low-grade serous ovarian cancer.
A Nomogram for Predicting Suicide Risk and Prognostic Factors in Bladder Cancer Patients Following Diagnosis: More Information Needed
Click on the article title to read more.
Chemotherapy May Be Safe and Effective for Pregnant Patients With Breast Cancer
An expert explained recent findings from a study of pregnant women with breast cancer who underwent chemotherapy and fared better than nonpregnant patients.
NMC appoints advisor to help improve FtP processes
The Nursing and Midwifery Council (NMC) has appointed a new adviser to help improve its fitness to practise (FtP) processes.
Cancer Therapies Approved by the FDA in December 2024
The FDA approved several drugs in December for the treatment of diseases, including pancreatic adenocarcinoma, lung cancer, skin cancer and graft-versus-host disease.
RCN chief ‘absolutely committed’ to improving pay for all nurses
The RCN chief has renewed her commitment to improving pay for all nursing staff across the UK in a New Year message to the profession.
RCN calls for restoration of UK investment in global health | Nursing Times
Read about new analysis by the Royal College of Nursing which shows the impact of a fall in foreign aid spending by the UK Government.
A Commitment to New Therapies for MPN Despite Scientific Challenges
One research noted the persistent efforts to develop new treatments for myeloproliferative neoplasms (MPNs), a commitment that remains strong despite some setbacks.